Topical and Injectable GHK-Cu Routes Compared Topical GHK-Cu has published cosmetic, wound, and trial-context evidence, while injectable GHK-Cu lacks an FDA-approved dosing label and is specifically discussed by FDA in relation to compounded injectable safety concerns [2], [3], [7], [8]
Another risk is that GI upset could cause GLP-1 users to quit taking the medications, leading them to regain the weight they lost
Users of the nasal spray form of the drug have reported side effects such as headaches, dizziness, panic attacks, nausea, vomiting, facial flushing, unusual moles, and more
Estudios en modelos murinos de inflamacin pulmonar aguda reportaron reduccin del dao tisular y supresin de la cascada inflamatoria
The stiffness lasts an hour, sometimes two
Goodman & Gilmans The Pharmacological Basis of Therapeutics